Philippine Nursing Board Exam Results | Practice Nursing Questions | Medical Surgical Nursing | Psychiatric Nursing | OB Nursing

FDA Approves Updated Warfarin (Coumadin) Prescribing Information

The U.S. Food and Drug Administration announced the approval of updated labeling for the widely used blood-thinning drug, Coumadin, to explain that people's genetic makeup may influence how they respond to the drug.

Manufacturers of warfarin, the generic version of Coumadin, are to add similar information to their products' labeling, FDA said.

The labeling change highlights the opportunity for healthcare providers to use genetic tests to improve their initial estimate of what is a reasonable warfarin dose for individual patients. Testing may help optimize the use of warfarin and lower the risk of bleeding complications from the drug.


Philippine Nursing


Post a Comment

Infolinks In Text Ads